Article Details
Retrieved on: 2021-07-26 07:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca PLC (LON:AZN) announced that Alexion's Ultomiris has been recommended for marketing authorisation in the EU for expanded use to ...
Article found on: www.proactiveinvestors.co.uk
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here